Creative Planning Ligand Pharmaceuticals Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Creative Planning holds 2,896 shares of LGND stock, worth $332,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,896

Previous 2,785 3.99%

Holding current value

$332,344

Previous $234,000 23.93%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$82.7 - $110.11 $9,179 - $12,222	111 Added 3.99%	2,896 $290,000
Q2 2024 Aug 15, 2024	BUY	$68.53 - $87.91 $190,856 - $244,829	2,785 New	2,785 $234,000
Q1 2020 May 05, 2020	SELL	$63.37 - $107.88 $614,372 - $1.05 Million	-9,695 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$96.94 - $113.59 $1,066 - $1,249	-11 Reduced 0.11%	9,695 $1.01 Million
Q3 2019 Nov 01, 2019	SELL	$86.25 - $120.16 $37,518 - $52,269	-435 Reduced 4.29%	9,706 $966,000
Q2 2019 Jul 26, 2019	SELL	$107.38 - $129.34 $3,650 - $4,397	-34 Reduced 0.33%	10,141 $1.16 Million
Q1 2019 Apr 24, 2019	BUY	$105.93 - $142.47 $67,371 - $90,610	636 Added 6.67%	10,175 $1.28 Million
Q4 2018 Feb 01, 2019	SELL	$128.36 - $272.13 $238,492 - $505,617	-1,858 Reduced 16.3%	9,539 $1.29 Million
Q3 2018 Oct 25, 2018	BUY	$211.18 - $274.49 $159,652 - $207,514	756 Added 7.1%	11,397 $3.13 Million
Q2 2018 Jul 20, 2018	BUY	$150.77 - $207.98 $189,517 - $261,430	1,257 Added 13.4%	10,641 $2.2 Million
Q1 2018 Apr 18, 2018	SELL	$138.63 - $182.62 $13,724 - $18,079	-99 Reduced 1.04%	9,384 $1.55 Million
Q4 2017 Jan 17, 2018	SELL	$128.36 - $147.04 $24,773 - $28,378	-193 Reduced 1.99%	9,483 $1.3 Million
Q3 2017 Oct 17, 2017	BUY	$120.91 - $137.94 $1.17 Million - $1.33 Million	9,676	9,676 $1.32 Million

Others Institutions Holding LGND

# of Institutions

260

Shares Held

18M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Ligand Pharmaceuticals Inc Transaction History